1
Registered trials
1
Recruiting
1
Unique sponsors
2
Unique IMPs
0
Commercial trials
Drug classes (ATC)
J
Anti-infectives (ATC J)
1
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (human)
1 substance
Unknown / small molecule
1 substance
Phase III/IV:
1
Phase III/IV
1 trial-
RecruitingAssistance Publique Hopitaux De Paris AcademicADALIMUMAB; ISONIAZID, RIFAMPICIN
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Assistance Publique Hopitaux De Paris | Academic | 1 | Phase III/IV | 1 |
New trials by year
2024
1